ALKBH5 and cancer: ALKBH5, by reducing m6A, enhances ubiquitin‐specific protease 1 (USP1) expression that regulates chemoresistance by upregulating Aurora B.[80] Thus, m6A modification regulates apoptosis in cancer therapy resistance (Table5).